4-MMC, commonly known as mephedrone (IUPAC: 2-(methylamino)-1-(4-methylphenyl)-1-propanone), is a synthetic cathinone belonging to the β-keto amphetamine class. It is characterized by a methyl group at the para position of the phenyl ring and a cathinone backbone, making it structurally related to methcathinone and other substituted cathinones. The compound typically appears as a white to off-white crystalline powder and is most often supplied in salt form, such as the hydrochloride.
Pharmacological Profile:
4-MMC acts as a potent central nervous system stimulant and entactogenic agent. It is reported to increase extracellular levels of dopamine, norepinephrine, and serotonin through a combination of neurotransmitter release and reuptake inhibition. These mechanisms account for its pronounced stimulant and mood-elevating properties. The substance has no approved medical or therapeutic use.
Health and Regulatory Considerations:
Extensive reports associate 4-MMC with significant health risks, including cardiovascular toxicity, hyperthermia, neurotoxicity, dehydration, and psychological disturbances. Due to its high abuse potential and documented harms, 4-MMC is classified as a controlled substance in most countries worldwide.
